Search Results - "Gether, Ida M."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    New Avenues in the Regulation of Gallbladder Motility—Implications for the Use of Glucagon-Like Peptide–Derived Drugs by Gether, Ida M, Nexøe-Larsen, Christina, Knop, Filip K

    “…Abstract Context Several cases of cholelithiasis and cholecystitis have been reported in patients treated with glucagon-like peptide 1 (GLP-1) receptor…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Colesevelam has no acute effect on postprandial GLP-1 levels but abolishes gallbladder refilling by Gether, Ida M, Bahne, Emilie, Nerild, Henriette H, Rehfeld, Jens F, Hartmann, Bolette, Holst, Jens J, Vilsbøll, Tina, Sonne, David P, Knop, Filip K

    Published in European journal of endocrinology (30-03-2024)
    “…Colesevelam, a bile acid sequestrant approved for the treatment of hypercholesterolaemia, improves glycaemic control in type 2 diabetes. We hypothesised that…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Gastric Aspiration Improves Postprandial Glucose Tolerance Without Causing a Compensatory Increase in Appetite and Food Intake by Gether, Ida M., Jensen, Marie M., Nexøe-Larsen, Christina C., Jorsal, Tina, Gasbjerg, Lærke S., Naver, Lars, Rehfeld, Jens F., Holst, Jens J., Vilsbøll, Tina, Knop, Filip K.

    Published in Obesity surgery (01-04-2022)
    “…Introduction AspireAssist® allows aspiration of ~30% of an ingested meal through a percutaneous gastrostomy tube, reducing caloric uptake. We evaluated the…”
    Get full text
    Journal Article
  7. 7

    Effects of glucagon-like peptides on gallbladder motility by Gether, Ida M, Nexøe-Larsen, Christina, Sonne, David P, Knop, Pilip K

    Published in Ugeskrift for læger (10-12-2018)
    “…As cases of gallbladder-related adverse events have been reported in patients treated with glucagon-like peptide (GLP)-1 receptor agonists and GLP-2 receptor…”
    Get more information
    Journal Article